Arcus Biosciences, Inc. (RCUS)
29.66
-0.47
(-1.56%)
USD |
NYSE |
Sep 04, 16:00
29.66
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Net Income (Annual) : -353.00M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -353.00M |
| December 31, 2024 | -283.00M |
| December 31, 2023 | -307.00M |
| December 31, 2022 | -267.00M |
| December 31, 2021 | 52.83M |
| Date | Value |
|---|---|
| December 31, 2020 | -122.86M |
| December 31, 2019 | -84.71M |
| December 31, 2018 | -49.59M |
| December 31, 2017 | -53.08M |
| December 31, 2016 | -17.97M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 316.89M |
| AVITA Medical, Inc. | -48.59M |
| Iovance Biotherapeutics, Inc. | -390.98M |
| Editas Medicine, Inc. | -160.06M |
| Recursion Pharmaceuticals, Inc. | -644.76M |